MARKET

ONCO

ONCO

Onconetix
NASDAQ
3.030
-0.730
-19.41%
After Hours: 3.090 +0.06 +1.98% 17:26 11/12 EST
OPEN
3.580
PREV CLOSE
3.760
HIGH
3.580
LOW
2.940
VOLUME
90.53K
TURNOVER
--
52 WEEK HIGH
1,610.00
52 WEEK LOW
2.940
MARKET CAP
1.78M
P/E (TTM)
-0.0015
1D
5D
1M
3M
1Y
5Y
1D
Onconetix, Inc. Stockholders Approve Reverse Stock Split Authority and Issuance of Up to 154,856,150 Shares
NASDAQ · 6h ago
Onconetix Stockholders Approve All Matters at Annual Meeting
TipRanks · 13h ago
Onconetix, Inc. Effects 1:10 Reverse Stock Split
NASDAQ · 3d ago
Realbotix Extends Merger Completion Date With Onconetix To March 31, 2027
Benzinga · 3d ago
Onconetix Inc trading resumes
TipRanks · 3d ago
Onconetix Inc trading halted, volatility trading pause
TipRanks · 3d ago
Onconetix Completes One-for-Ten Reverse Stock Split Adjustment
TipRanks · 3d ago
Weekly Report: what happened at ONCO last week (1102-1106)?
Weekly Report · 3d ago
More
About ONCO
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men’s health and oncology. The Company owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.

Webull offers Onconetix Inc stock information, including NASDAQ: ONCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONCO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONCO stock methods without spending real money on the virtual paper trading platform.